Xolair 150 mg solution for injection in pre-filled syringe clinical trials
5 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Parallel Group, Multicentre Study to Compare Efficacy, Safety, Pharmacodynamics, Pharmacokinetics, immunogenicity, of BP11 versus EU-Approved Xolair in patients With Chronic Spontaneous Urticaria Who Are Resistant to H1 Antagonist.
This study compares a new medicine (BP11) with an approved one (Xolair) for chronic hives that haven't responded to usual treatments. Researchers want to see if BP11 is safe and effective in reducing itching and other symptoms.
For: Chronic UrticariaHungary · Latvia · Bulgaria - AuthorisedTherapeutic exploratory (Phase II)
Prospective, open-label study to analyze the efficacy and safety of low-dose oral immunotherapy in children with severe IgE-mediated cow's milk allergy treated with omalizumab. ILO study.
This study is looking at a new way to treat children with a severe cow's milk allergy. It combines a special medicine called Xolair with small, increasing amounts of cow's milk to see if it can help children safely eat milk products.
For: Severe IgE-mediated cow's milk allergySpain - Ongoing, recruitingPhase III and phase IV (Integrated)
Extending omalizumab treatment intervals in patients with chronic spontaneous urticaria (EXOTIC trial): a multicentre, randomized, open-label, non-inferiority trial.
This study looks at whether people with ongoing hives (chronic spontaneous urticaria) can take their Xolair medicine less often. It wants to see if stretching out the time between doses works just as well to control their hives, compared to the usual schedule.
For: Chronic spontaneous urticariaDenmark - Ongoing, recruitingPhase III and phase IV (Integrated)
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST)
This study looks at a medicine called Xolair for people with narrowed arteries in their neck. Researchers want to see if Xolair can calm down certain immune cells, called mast cells, in these arteries. This might help prevent artery problems and improve health.
For: Carotid artery stenosisNetherlands - AuthorisedTherapeutic use (Phase IV)
Therapheutic optimization of omalizumab in allergic severe asthma patients by dose and frequency of administration adjustment
This study is looking at whether adults with severe allergic asthma can take a lower dose of their Xolair (omalizumab) medication and still control their asthma well. Researchers want to see if a 50% dose reduction keeps asthma stable, improves quality of life, and maintains lung function.
For: AsthmaSpain